Fig. 2.
Fig. 2. Activation of both p72syk and Lyn by pervanadate treatment of intact erythrocytes. / Human erythrocytes were incubated without (histogram 1) or with pervanadate (histograms 2-5) either in the absence (histograms 1 and 2) or presence of PP1 (histograms 3-5). Erythrocyte membranes were then rapidly isolated and treated with extraction buffer as described in “Materials and methods.” The extracted proteins were immunoprecipitated with either anti-Syk (A) or anti-Lyn (B) antibodies, and tyrosine kinase activities of the immune complexes were tested in vitro as described in “Materials and methods.” Aliquots of packed membranes were also subjected to SDS-PAGE, transferred to nitrocellulose membranes, and incubated with either anti-Syk or anti-Lyn antibody (insets in both panels). Reported values represent means of 4 separate experiments, with SE indicated by vertical bars.

Activation of both p72syk and Lyn by pervanadate treatment of intact erythrocytes.

Human erythrocytes were incubated without (histogram 1) or with pervanadate (histograms 2-5) either in the absence (histograms 1 and 2) or presence of PP1 (histograms 3-5). Erythrocyte membranes were then rapidly isolated and treated with extraction buffer as described in “Materials and methods.” The extracted proteins were immunoprecipitated with either anti-Syk (A) or anti-Lyn (B) antibodies, and tyrosine kinase activities of the immune complexes were tested in vitro as described in “Materials and methods.” Aliquots of packed membranes were also subjected to SDS-PAGE, transferred to nitrocellulose membranes, and incubated with either anti-Syk or anti-Lyn antibody (insets in both panels). Reported values represent means of 4 separate experiments, with SE indicated by vertical bars.

Close Modal

or Create an Account

Close Modal
Close Modal